MAIA Biotechnology Inc (MAIA) Financials

$1.31

$0.03 (2.34%)

As on 10-Sep-2026 16:00EDT

Market cap

$80 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

3.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	28.95	24.27	16.96	20.18	16.18	7.79
Operating Profit (EBIT)	-28.95	-24.27	-16.96	-20.18	-16.18	-7.79
Other Income	--	--	--	--	--	--
Profit before Tax	-26.47	-22.40	-23.25	-19.77	-15.77	-12.58
Provision for Tax	0.37	--	-0.08	-0.18	0.04	0.71
Profit after Tax (Net Income)	-26.85	-22.40	-23.25	-19.77	-15.77	-12.50
Minority Interest	--	--	--	--	--	0.07
Consolidated Profit	--	--	--	--	--	-12.50

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	20.68	2.38	3.63	0.48	8.51	9.18
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.31	1.49	2.69	2.15	0.25	0.96
Current Liabilities	6.26	5.84	3.83	4.94	3.27	2.15
Total Liabilities	34.50	9.70	10.16	7.57	12.02	11.33

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.00	0.00	0.00	0.00	0.21	0.65
Current Assets	28.24	9.70	10.15	7.56	11.81	10.67
Total Assets	56.48	9.70	10.16	7.57	12.02	11.33
Total Debt*	--	--	--	--	--	--
Net Current Assets	--	3.87	6.32	2.63	8.54	8.53

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-18.84	-15.70	-13.07	-12.10	-4.12
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	17.91	18.18	9.27	12.48	14.03
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.71	-0.70	-0.89	-1.16	-1.70	-1.18
Cash EPS ($)	--	-0.70	-0.89	-1.16	-1.70	-1.18
Adjusted Book Value ($)	--	0.07	0.14	0.03	0.92	0.86
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.59	-0.60	-0.77	-1.30	-0.39
Free Cash Flow per Share ($)	--	-0.59	-0.60	-0.77	-1.30	-0.39

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-745.24	-1,131.02	-440.12	-178.29	-396.39
ROE (%)	-232.92	-745.24	-1,131.02	-440.12	-178.29	-427.84
ROA (%)	-73.99	-225.54	-262.44	-201.88	-135.07	-207.13
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-88,147.12	--	-15.22	-24.77	-4.17	-11.31
Net Profit Growth (%)	-66.00	3.69	-17.61	-25.39	-26.12	-88.41
EPS Growth (%)	-20.24	0.22	0.24	0.32	-0.45	-0.88
Book Value Growth (%)	165.81	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-2.19	-2.23	-1.01	-2.06	--
Price / Book Value	3.83	20.68	14.25	41.62	3.83	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.34	384.39	-1.81	-0.64	-1.37	--
Close Price ($)	--	1.53	1.98	1.17	3.51	--
High Price ($)	--	2.74	5.99	5.22	9.64	--
Low Price ($)	--	0.87	0.99	0.82	3.10	--
Market Cap ($ Cr)	80.30	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	0.01
Current Ratio	4.51	1.66	2.65	1.53	3.61	4.97
Quick Ratio	4.51	--	--	--	--	4.99
Interest Coverage	--	--	-407,977.42	-2,940.75	-2,321.83	-18.76

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.